Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
for Angioimmunoblastic T-cell Lymphoma
Sites in Bellevue, Omaha +84 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT04803201·Phase 2·Recruiting·Listed Mar 2021